A
Anders Heijl
Researcher at Lund University
Publications - 195
Citations - 20282
Anders Heijl is an academic researcher from Lund University. The author has contributed to research in topics: Glaucoma & Intraocular pressure. The author has an hindex of 59, co-authored 191 publications receiving 18350 citations. Previous affiliations of Anders Heijl include University College London & Malmö University.
Papers
More filters
Journal ArticleDOI
Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
TL;DR: The first adequately powered randomized trial with an untreated control arm to evaluate the effects of IOP reduction in patients with open-angle glaucoma who have elevated and normal IOP showed considerable beneficial effects of treatment that significantly delayed progression.
Journal ArticleDOI
Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
TL;DR: Patients treated in the EMGT had half of the progression risk of control patients, including the effect of EMGT treatment, and the magnitude of initial IOP reduction was a major factor influencing outcome.
Journal ArticleDOI
Predictors of long-term progression in the early manifest glaucoma trial.
TL;DR: Treatment and follow-up IOP continued to have a marked influence on progression, regardless of baseline IOP, and lower systolic perfusion pressure, lower syStolic BP, and cardiovascular disease history emerged as new predictors, suggesting a vascular role in glaucoma progression.
Journal ArticleDOI
Early Manifest Glaucoma Trial: design and baseline data.
TL;DR: The EMGT is the first large randomized, clinical trial to evaluate the role of immediate pressure reduction, as compared to no initial reduction, in patients with early glaucoma and normal or moderately elevated IOP, and its results will have implications for the clinical management of glau coma.